Oct 31, 2024 12:59 AM
BACK TO TOP
KSE100
90,286.56
-577.53
(-0.64%)
ALLSHR
57,642.35
-282.08
(-0.49%)
KSE30
28,343.09
-212.33
(-0.74%)
KMI30
136,138.90
-811.40
(-0.59%)
BKTI
22,310.11
-261.96
(-1.16%)
OGTI
21,809.60
39.43
(0.18%)
KMIALLSHR
39,352.97
-151.14
(-0.38%)
PSXDIV20
35,155.79
-13.36
(-0.04%)
UPP9
27,400.40
-290.56
(-1.05%)
NITPGI
22,002.76
-92.31
(-0.42%)
NBPPGI
24,645.63
-58.67
(-0.24%)
MZNPI
17,986.73
-84.53
(-0.47%)
JSMFI
25,652.01
-192.12
(-0.74%)
ACI
13,793.85
-261.26
(-1.86%)
JSGBKTI
24,653.36
-178.70
(-0.72%)
MII30
12,724.95
-76.73
(-0.60%)
HBLTTI
15,058.22
18-10-2024
8.04
(0.05%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.269.76
12.30
(4.78%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Wed, Oct 30, 2024 4:10 PM
REG
FUT
ODL
Open
268.00
High
274.99
Low
261.10
Volume
822,283
CIRCUIT BREAKER
231.71 — 283.21
DAY RANGE
261.10 — 274.99
52-WEEK RANGE
74.00 — 274.99
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
257.46
VAR
23.50
HAIRCUT
35.00
P/E Ratio (TTM) **
19.05
1-Year Change *
254.02%
YTD Change *
225.05%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Erum Shakir RahimCEO
Lai Kuen GohChairperson
Hina MirCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
85,909,732.91
Shares
318,467,278
Free Float
63,693,456
Free Float
20.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 29, 2024GLAXO | GlaxoSmithKline Pakistan Limited TRANSMISSION OF QUARTERLY ACCOUNTS FOR THE PERIOD ENDED SEP. 30, 2024 PDF
Oct 28, 2024Financial Results for the nine months ended September 30,2024 View   PDF
Oct 28, 2024Financial results for the nine months ended September 20, 2024
REVOKED
View   PDF
Aug 29, 2024GLAXO | GlaxoSmithKline Pakistan Limited Transmission of Half yearly Report for the Period Ended June 30, 2024 PDF
Aug 23, 2024GLAXO | GlaxoSmithKline Pakistan Limited Financial Results for the Half Year Ended June 30 2024 PDF
Jul 23, 2024GLAXO | GlaxoSmithKline Pakistan Limited Other Than Financial Results PDF
Apr 30, 2024Transmission of Quarterly Account for the Period Ended March 31, 2024 View   PDF
Apr 26, 2024Financial Results for the quarter ended March 31,2024 View   PDF
Apr 3, 2024Transmission of Annual Report for the year ended December 31, 2023 View   PDF
Mar 26, 2024GLAXO | GlaxoSmithKline Pakistan Limited FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 - GLAXO PDF
DateTitleDocument
Oct 21, 2024GLAXO | GlaxoSmithKline Pakistan Limited Board Meeting PDF
Aug 16, 2024GLAXO | GlaxoSmithKline Pakistan Limited Board Meeting PDF
Jul 30, 2024GLAXO | GlaxoSmithKline Pakistan Limited GSK Board Meeting Result other than Financial Results July 30 2024 PDF
Apr 24, 2024Certified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on April 24, 2024 View   PDF
Apr 19, 2024Board Meeting for the quarter ended March 31, 2024 View   PDF
Apr 3, 2024GLAXO | GlaxoSmithKline Pakistan Limited - Notice of Annual General Meeting PDF
Mar 19, 2024Board of Directors Meeting - 4th Quarter 2023 on 26 March 2024 View   PDF
Oct 17, 2023Board Of Directors Meeting View   PDF
Aug 15, 2023Board Meeting View   PDF
May 24, 2023Certified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on May 24, 2023 View   PDF
DateTitleDocument
Oct 4, 2024GLAXO | GlaxoSmithKline Pakistan Limited UNUSUAL MOVEMENT IN THE PRICE OF SHARES OF GlaxoSmithKline Pakistan Limited PDF
Jun 11, 2024Appointment of Company Secretary View   PDF
Jun 10, 2024Resignation of Company Secretary View   PDF
May 20, 2024Unusual Movement in the price of shares View   PDF
Apr 23, 2024GLAXO | GlaxoSmithKline Pakistan Limited Material Information PDF
Dec 13, 2023Presentation of Corporate Briefing Session - 2023 View   PDF
Dec 11, 2023GLAXO | GlaxoSmithKline Pakistan Limited- CORPORATE BRIEFING SESSION - 2023 PDF
Jun 2, 2023Material informaiton View   PDF
Jun 2, 2023Change of Company Secretary View   PDF
May 30, 2023Material Information - Resignation of Company Secretary View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2023202220212020
Sales49,661,27741,841,58536,660,77235,090,112
Profit after Taxation533,9532,462,8925,354,4093,375,240
EPS1.687.7316.8110.60
Q3 2024Q2 2024Q1 2024Q3 2023
Sales14,730,94013,254,79715,616,12613,770,544
Profit after Taxation1,927,1341,088,869565,281(69,790)
EPS6.053.421.78(0.22)
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2023202220212020
Gross Profit Margin (%)7.0517.4026.5621.47
Net Profit Margin (%)1.085.8914.619.62
EPS Growth (%)(78.27)(54.02)58.5810.99
PEG(0.63)(0.21)0.141.65

Payouts

DateFinancial ResultsDetailsBook Closure
February 28, 2022 11:32 AM31/12/2021(YR) 70%(F) (D) 19/04/2022 - 25/04/2022
March 10, 2021 3:45 PM31/12/2020(YR) 65%(F) (D) 21/04/2021 - 27/04/2021
March 11, 2020 5:58 PM31/12/2019(YR) 60%(F) (D) 15/05/2020 - 21/05/2020
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014

Financial Reports